Custom Search

Brand Name(s): Ketek, Ketek Pak
CAS nº: 191114-48-4
(tel ith row MY sin)

About Ketolides

This new site is dedicated exclusively to ketolides, a relatively new family of semisynthetic antimicrobials (antibiotic).

It provides you with the most extensive product information and up-to-date resources regarding this medication, including related news articles, medical studies, an image library and all the necessary information on dosage and side effects.

Whether you are an average consumer or a pharma industry professional, you can now find out everything you need to know about telithromycin on this reference site, as well as take part in our open discussion forum by sharing your own knowledge and experience with people who are using this medication.

This unique site will also offer you inside industry news on which companies or organizations are playing an important part in its research, development, production and promotion. It is your one-stop site for a total ketolide experience! 

Why is this medication prescribed?

Ketolides are antibiotics belonging to the macrolide group. They are derived from erythromycin by substituting the cladinose sugar with a keto-group and attaching a cyclic carbamate group in the lactone ring. These modifications give ketolides much broader spectrum than other macrolides. Moreover, ketolides are effective against macrolide-resistant bacteria, due to their ability to bind at two sites at the bacterial ribosome.

The only ketolide currently on the market is telithromycin, which is sold under the brand name of Ketek® and manufactured by Sanofi-Aventis.

See more Product Info

Latest News

Ketek Safety Concerns Persist

For months, there have been growing concerns over the safety of Ketek, an antibiotic that has...

[more]

Public Communication - Health Canada Endorsed Important Safety Information on Ketek(telithromycin)

Sanofi-aventis Canada Inc., in consultation with Health Canada, would like to inform Canadian...

[more]

FDA Announces Label and Indication Changes for the Antibiotic Ketek

The Food and Drug Administration (FDA) today announced revisions to the labeling for the antibiotic...

[more]

First Quarter 2006 Product Candidate Highlights

Advanced Life Sciences is developing cethromycin, a novel once-a-day ketolide antibiotic in...

[more]

FDA Warns of Liver Failure With Telithromycin

The warning, which Ketek’s manufacturer is adding to the drug’s labeling, results from FDA’s...

[more]

Use of this site is subject to the following terms of use